Paid Clinical Trials Indiana

Discover 705 paid clinical trials in Indiana. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 705

Aromatase InhibitorAromatase Inhibitor Clinical Trial

Recruiting

Sponsor:

National Institute of General Medical Sciences (NIGMS)

Location:

Indianapolis IN, Ann Arbor MI, Baltimore MD

Code:

NCT00228956

Conditions

Breast Cancer

Eligibility Criteria

Sex: Female

Age: 40 - 70

Healthy Volunteers: Not accepted

Interventions

pharmacodynamic analysis

Neoadjuvant Chemotherapy vs. ChemoradiotherapyNeoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer

Recruiting

PHASE3

Sponsor:

Canadian Cancer Trials Group

Location:

Danville IL, Greenville OH, Urbana IL, Cincinnati OHshow 45 more

Code:

NCT06205485

Conditions

Rectal Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Leucovorin

Oxaliplatin

Fluoruracil

Capecitabine

Radiation

OfatumumabPharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab

Recruiting

PHASE3

Sponsor:

Novartis Pharmaceuticals

Location:

Indianapolis IN, Centerville OH, Saint Louis MO, Rochester Hills MIshow 20 more

Code:

NCT06869785

Conditions

Relapsing Multiple Sclerosis (RMS)

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Ofatumumab approved dose

Ofatumumab new dose

CFT1946A Study to Characterize the Safety, Tolerability, and Preliminary Efficacy of CFT1946 As Monotherapy and Combination Therapy in Subjects with BRAF V600 Mutant Solid Tumors

Recruiting

PHASE1

PHASE2

Sponsor:

C4 Therapeutics, Inc.

Location:

Indianapolis IN, St. Louis MO, Nashville TN, Madison WIshow 7 more

Code:

NCT05668585

Conditions

Solid Tumors

Melanoma

NSCLC

CRC

ATC

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

CFT1946

Trametinib

Cetuximab

Genetic RegistryParkinson's Foundation PD GENEration Genetic Registry

Recruiting

Sponsor:

Parkinson's Foundation

Location:

Indianapolis IN, Cincinnati OH, Chicago IL, Lexington KYshow 35 more

Code:

NCT04994015

Conditions

Parkinson's Disease

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Lab Assay for seven genetic variants for Parkinson's Disease

Observational StudyEsophageal Impedance and Manometry Measurements and Dysphagia Symptom Scoring

Recruiting

Sponsor:

Indiana University

Location:

Indianapolis IN

Code:

NCT04503785

Conditions

Dysphagia, Esophageal

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Accepted

Interventions

Manometry

Circulating Tumor CellsCirculating Tumor Cells (CTC) in Lung Cancer

Recruiting

Sponsor:

Shadia Jalal

Location:

Indianapolis IN

Code:

NCT02630615

Conditions

Lung Neoplasms

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Blood draw

VET3-TGIA Study of VET3-TGI in Patients With Solid Tumors

Recruiting

PHASE1

Sponsor:

KaliVir Immunotherapeutics

Location:

Indianapolis IN, Pittsburgh PA, Dallas TX, Houston TXshow 3 more

Code:

NCT06444815

Conditions

Solid Tumor, Adult

Microsatellite Stable Colorectal Cancer

Head and Neck Squamous Cell Carcinoma

Cervical Cancer

Kidney Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

VET3-TGI

Pembrolizumab

VITRAKVIStudy to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body

Recruiting

Sponsor:

Bayer

Location:

Multiple Locations, Terre Haute IN, Fort Wayne IN, Columbus OHshow 42 more

Code:

NCT04142437

Conditions

Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

larotrectinib(Vitrakvi, BAY2757556)

ABBV-383A Study to Assess Adverse Events of Intravenously (IV) Infused ABBV-383 in Adult Participants With Relapsed or Refractory Multiple Myeloma

Recruiting

PHASE1

Sponsor:

TeneoOne Inc.

Location:

Cincinnati OH, Fort Wayne IN, Hinsdale IL, Nashville TNshow 19 more

Code:

NCT05650632

Conditions

Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

ABBV-383

Popular cities in Indiana

Indianapolis South Bend Fort Wayne Evansville